141 related articles for article (PubMed ID: 3261294)
1. Physiologic inhibition of human activated protein C by alpha 1-antitrypsin.
Heeb MJ; Griffin JH
J Biol Chem; 1988 Aug; 263(24):11613-6. PubMed ID: 3261294
[TBL] [Abstract][Full Text] [Related]
2. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
[TBL] [Abstract][Full Text] [Related]
3. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
[TBL] [Abstract][Full Text] [Related]
4. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
[TBL] [Abstract][Full Text] [Related]
5. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel recombinant serpin with potential antithrombotic properties.
Hopkins PC; Crowther DC; Carrell RW; Stone SR
J Biol Chem; 1995 May; 270(20):11866-71. PubMed ID: 7744836
[TBL] [Abstract][Full Text] [Related]
7. Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.
Shen L; Dahlbäck B; Villoutreix BO
Biochemistry; 2000 Mar; 39(11):2853-60. PubMed ID: 10715104
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of activated protein C by recombinant alpha 1-antitrypsin variants with substitution of arginine or leucine for methionine358.
Heeb MJ; Bischoff R; Courtney M; Griffin JH
J Biol Chem; 1990 Feb; 265(4):2365-9. PubMed ID: 2298753
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.
España F; Hendl S; Gilabert J; Estellés A; Aznar J
Thromb Res; 1993 Jun; 70(5):375-84. PubMed ID: 8397450
[TBL] [Abstract][Full Text] [Related]
10. Turnover of *I-protein C inhibitor and *I-alpha 1-antitrypsin and their complexes with activated protein C.
Laurell M; Stenflo J; Carlson TH
Blood; 1990 Dec; 76(11):2290-5. PubMed ID: 2175221
[TBL] [Abstract][Full Text] [Related]
11. Resistance to inhibition by alpha-1-anti-trypsin and species specificity of a chimeric human/bovine protein C.
Holly RD; Foster DC
Biochemistry; 1994 Feb; 33(7):1876-80. PubMed ID: 8110791
[TBL] [Abstract][Full Text] [Related]
12. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors.
Rezaie AR; Esmon CT
J Biol Chem; 1993 Sep; 268(27):19943-8. PubMed ID: 8104182
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons.
España F; Gruber A; Heeb MJ; Hanson SR; Harker LA; Griffin JH
Blood; 1991 Apr; 77(8):1754-60. PubMed ID: 1849759
[TBL] [Abstract][Full Text] [Related]
14. Inhibition and complexation of activated protein C by two major inhibitors in plasma.
Heeb MJ; España F; Griffin JH
Blood; 1989 Feb; 73(2):446-54. PubMed ID: 2917184
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
Chan AK; Patel S; Male C; Berry LR; Mitchell LG
Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
[TBL] [Abstract][Full Text] [Related]
16. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation.
Heeb MJ; Mosher D; Griffin JH
Blood; 1989 Feb; 73(2):455-61. PubMed ID: 2521800
[TBL] [Abstract][Full Text] [Related]
17. α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.
Martos L; Ramón LA; Oto J; Fernández-Pardo Á; Bonanad S; Cid AR; Gruber A; Griffin JH; España F; Navarro S; Medina P
Thromb Haemost; 2018 Apr; 118(4):630-638. PubMed ID: 29448296
[TBL] [Abstract][Full Text] [Related]
18. Isolation, chemical, and physical properties of alpha-1-antitrypsin.
Musiani P; Tomasi TB
Biochemistry; 1976 Feb; 15(4):798-804. PubMed ID: 2286
[TBL] [Abstract][Full Text] [Related]
19. Identification of divalent metal ion-dependent inhibition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin.
Heeb MJ; Gruber A; Griffin JH
J Biol Chem; 1991 Sep; 266(26):17606-12. PubMed ID: 1716632
[TBL] [Abstract][Full Text] [Related]
20. Mouse plasma trypsin inhibitors. Isolation and characterization of alpha-1-antitrypsin and contrapsin, a novel trypsin inhibitor.
Takahara H; Sinohara H
J Biol Chem; 1982 Mar; 257(5):2438-46. PubMed ID: 6977540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
